Cancer Biomarkers

A disease biomarker refers to a substance or process that is characteristic of the nearness of malignancy in the body. A biomarker might be a particle emitted by a tumor or a particular reaction of the body to the nearness of malignancy. Hereditary, epigenetic, proteomic, glycemic, and imaging biomarkers can be utilized for disease determination, guess, and the study of disease transmission. While some malignancy biomarkers can be utilized to foresee how forcefully your tumor will develop, and are in this way valuable for surveying your visualization, the most encouraging utilization of biomarkers today is to recognize which treatments a patient's growth could conceivably react to.

• Imaging Biomarkers

• Clinical Biomarkers

• Genetic Biomarkers

• Predictive Cancer Biomarkers

• Molecular Biomarkers

• Cell Free Biomarkers

    Related Conference of Cancer Biomarkers

    December 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Dubai, UAE
    December 11-12, 2024

    34th Experts Meet On Cancer Research & Therapy

    Paris, France
    December 12-13, 2024

    44th Euro Congress on Cancer Science & Therapy

    Rome, Italy
    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK
    March 24-25, 2025

    10th World Conference on Breast and Cervical Cancer

    Paris, France
    April 07-08, 2025

    15th World Congress on Breast Cancer

    Vancouver, Canada
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands
    July 14-15, 2025

    5th World Congress on Breast Cancer

    Berlin, Germany
    October 20-21, 2025

    21st International Conference on Cancer Research

    Barcelona, Spain

    Cancer Biomarkers Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in